CLNN
Clene Inc. News
Sign up for free!
Get instant access to all of our market news and analysis with our free REST API.
Latest news
Live response for past 24 hours
{
"meta": {
"found": 1,
"returned": 1,
"limit": 10,
"page": 1
},
"data": [
{
"uuid": "d76873cc-7c55-4c27-a512-8fe48152aac0",
"title": "Clene to Present at Upcoming May Conferences",
"description": "SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene...",
"keywords": "Nasdaq:CLNN, Clene Inc.",
"snippet": "SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- Clene Inc. (Nasdaq: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nano...",
"url": "https://www.globenewswire.com/news-release/2024/05/14/2881309/0/en/Clene-to-Present-at-Upcoming-May-Conferences.html",
"image_url": "https://ml.globenewswire.com/Resource/Download/e9de96a4-582e-4975-8e43-6f3e6259c075",
"language": "en",
"published_at": "2024-05-14T12:00:00.000000Z",
"source": "globenewswire.com",
"relevance_score": null,
"entities": [
{
"symbol": "CLNN",
"name": "Clene Inc.",
"exchange": null,
"exchange_long": null,
"country": "us",
"type": "equity",
"industry": "Healthcare",
"match_score": 105.0639,
"sentiment_score": 0.39404,
"highlights": [
{
"highlight": "SALT LAKE CITY, May 14, 2024 (GLOBE NEWSWIRE) -- <em>Clene</em> <em>Inc</em>.",
"sentiment": 0,
"highlighted_in": "main_text"
},
{
"highlight": "(<em>Nasdaq</em>: <em>CLNN</em>) (along with its subsidiaries, “<em>Clene</em>”) and its wholly owned subsidiary <em>Clene</em> Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis and multiple sclerosis, today announced",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "Healthcare Conference\n\nDate: May 22, 2024\n\nLocation: Virtual\n\nFormat: 1x1 meetings\n\nAbout <em>Clene</em>\n\n<em>Clene</em> <em>Inc</em>., (<em>Nasdaq</em>: <em>CLNN</em>) (along with its subsidiaries, “<em>Clene</em>”) and its wholly owned subsidiary <em>Clene</em> Nanomedicine Inc., is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat",
"sentiment": 0.7964,
"highlighted_in": "main_text"
},
{
"highlight": "CNM-Au8® is a federally registered trademark of <em>Clene</em> Nanomedicine, Inc. The company is based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland. For more information, please visit www.clene.com or follow us on X (formerly Twitter) and LinkedIn.\n\nContacts:",
"sentiment": 0.3774,
"highlighted_in": "main_text"
},
{
"highlight": "<em>Clene</em> to Present at Upcoming May Conferences",
"sentiment": 0,
"highlighted_in": "title"
}
]
}
],
"similar": []
}
]
}
Sentiment
Live response for past 24 hours
{
"meta": {
"returned": 1,
"limit": 10
},
"data": [
{
"key": "CLNN",
"total_documents": 1,
"sentiment_avg": 0.39403998851776123
}
]
}
Other details
Exchange
- NASDAQ Stock Exchange
- equity
- Healthcare
- us